Range Low Price High Price Comment
30 days $0.0500 $0.0500 Monday, 4th Mar 2024 CFRX stock ended at $0.0500. During the day the stock fluctuated 0% from a day low at $0.0500 to a day high of $0.0500.
90 days $0.0457 $0.0620
52 weeks $0.0430 $3.95

Historical ContraFect Corporation prices

Date Open High Low Close Volume
2020-10-13 $5.58 $5.69 $5.51 $5.58 98 126
2020-10-12 $5.43 $5.60 $5.40 $5.60 118 979
2020-10-09 $5.44 $5.45 $5.29 $5.43 73 759
2020-10-08 $5.47 $5.49 $5.36 $5.42 74 601
2020-10-07 $5.33 $5.50 $5.17 $5.45 158 477
2020-10-06 $5.30 $5.46 $5.20 $5.30 111 154
2020-10-05 $5.18 $5.44 $5.13 $5.28 137 982
2020-10-02 $5.16 $5.27 $5.09 $5.16 70 496
2020-10-01 $5.32 $5.32 $5.12 $5.20 78 710
2020-09-30 $5.29 $5.40 $5.11 $5.28 97 045
2020-09-29 $5.22 $5.44 $5.22 $5.29 122 385
2020-09-28 $5.21 $5.30 $5.07 $5.24 160 075
2020-09-25 $5.10 $5.30 $5.09 $5.15 161 056
2020-09-24 $5.28 $5.28 $5.05 $5.13 137 234
2020-09-23 $5.37 $5.38 $5.21 $5.24 134 260
2020-09-22 $5.35 $5.48 $5.13 $5.41 225 796
2020-09-21 $5.61 $5.70 $5.27 $5.34 295 679
2020-09-18 $5.78 $5.97 $5.63 $5.73 1 408 542
2020-09-17 $5.40 $5.84 $5.38 $5.69 205 861
2020-09-16 $5.62 $5.72 $5.48 $5.52 215 751
2020-09-15 $5.68 $5.91 $5.53 $5.59 218 888
2020-09-14 $5.49 $5.74 $5.48 $5.66 172 807
2020-09-11 $5.48 $5.62 $5.28 $5.39 124 203
2020-09-10 $5.53 $5.76 $5.26 $5.45 197 794
2020-09-09 $5.11 $5.62 $5.08 $5.48 306 371
Click to get the best stock tips daily for free!

About ContraFect Corporation

ContraFect ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT